Review
Open access
Aug 2026
Targeting IFN signaling as therapeutic option for lupus nephritis.
The course of systemic lupus erythematosus (SLE) is highly heterogeneous, with clinical manifestations varying considerably among patients and multiple immune pathways implicated in disease progression. Regardless of this variability, lupus nephritis (LN) is a frequent organ manifestation of SLE and often progresses to...
M. Meineck, Janine Riepl, P. Claßen et al.
· Autoimmunity · 0 citations